Clinical Trial Update: A Study to Evaluate Safety and Efficacy of KM-819 in Healthy Adults and Participants with Parkinson's Disease [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update for KM-819 evaluating safety and efficacy in healthy adults and participants with Parkinson disease. The study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• KM-819 (KM-819)

Snippet

Sponsor: FAScinate Therapeutics Inc. | Conditions: Parkinson Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING